SOST and chronic myelogenous leukemia, BCR-ABL1 positive: A subgroup of 65 T1D/57 controls had BTMs and sclerostin measurements, and those with T1D also had serum pentosidine (16.8[8.2–32.0] ng/mL) and CML [48.0 ± 16.8] ng/mL) measured.